Evaporation Residue Testing for Medical Devices: Standards, Methods, and Applications

Evaporation residue testing is a fundamental chemical analysis used to quantify the total amount of non-volatile substances that migrate from medical device materials into aqueous extracts under simulated clinical use conditions. This test provides critical quality and safety data for disposable infusion, transfusion, and injection devices, supporting regulatory submissions, batch release, and material change control. This article explains the technical principles, applicable standards such as GB/T 14233.1 and ISO 10993, sample types, testing procedures, and typical acceptance criteria for evaporation residue determination in medical devices.

Technical Overview

Evaporation residue determination measures the total mass of non-volatile migratable substances released from a medical device or its constituent materials into a defined extraction medium, typically purified water, under controlled laboratory conditions. During the test, a measured volume of the device extract is evaporated to dryness, and the remaining residue is dried to constant weight and quantified gravimetrically. The result serves as a screening indicator of overall extractable content, reflecting raw material purity, residual processing aids, plasticizers, oligomers, lubricants, stabilizers, and cleaning residues.

In China, the primary standard governing this test is GB/T 14233.1, which specifies chemical analysis methods for medical infusion, transfusion, and injection equipment. Product-specific standards such as GB 8368 for disposable sterile infusion sets, GB 8369 for transfusion sets, and GB/T 15810 for disposable syringes reference this method and define acceptance limits. Internationally, evaporation residue data complement the chemical characterization framework of the ISO 10993 series, particularly ISO 10993-12 for sample preparation and ISO 10993-17 and ISO 10993-18 for toxicological risk assessment and extractables-leachables studies.

Because the test is non-specific and captures the aggregate of all non-volatile migrants, it is widely used by accredited third-party laboratories, manufacturers, and regulatory reviewers as a first-tier quality control metric. Elevated residue values typically trigger further targeted analysis, such as gas chromatography-mass spectrometry or inductively coupled plasma spectroscopy, to identify the specific substances responsible.

Testing Samples

Infusion, Transfusion, and Injection Devices

Disposable sterile infusion sets, blood transfusion sets, extension tubing, intravenous cannulae, and single-use syringes represent the largest category of samples. These devices have direct, sustained contact with circulating fluids, making the control of migratable substances essential. Testing is normally performed on the complete device in its final sterilized condition so that sterilization-related extractables are captured.

Catheters and Tubing Products

Urinary catheters, central venous catheters, endotracheal tubes, suction catheters, and peritoneal dialysis catheters are tested because polymeric components such as PVC, polyurethane, silicone, and latex can release plasticizers, curing residues, and oligomers into contact fluids.

Containers and Blood Contact Articles

Intravenous solution bags, parenteral nutrition containers, blood collection bags, empty containers for parenteral administration, and their elastomeric closure systems are evaluated to confirm that container materials do not contribute excessive non-volatile substances to stored liquids over the product shelf life.

Extracorporeal Circulation and Anesthesia Equipment

Oxygenators, hemodialyzers, extracorporeal blood circuit tubing, anesthesia breathing circuits, masks, and reservoirs are tested to characterize the aggregate release of process residues and material additives under simulated-use extraction.

Raw Materials and Components

Polymer granules, films, sheets, gaskets, seals, coatings, and adhesives submitted for incoming material qualification or supplier change evaluation are extracted at a defined surface-area-to-volume or mass-to-volume ratio to generate comparable residue data independent of finished device geometry.

Testing Items

Core test items and related chemical indices typically evaluated alongside evaporation residue include:

• Evaporation residue in water extract, expressed in milligrams per test volume or milligrams per liter
• Evaporation residue in acid extract, where product standards specify an acidic medium to simulate additional clinical exposure scenarios
• Reducing substances (easily oxidizable material) determined by potassium permanganate titration
• Heavy metals content determined by colorimetric comparison or atomic spectroscopy
• Acidity and alkalinity of aqueous extracts by titration
• Ultraviolet absorbance of extracts as a supplementary indicator of aromatic migrants
• Conductivity and pH of extracts for electrolytic impurity screening
• Declaring substances of concern, including specific plasticizers such as DEHP, by targeted chromatographic methods when justified

Testing Methods

Sample Preparation and Extraction

Under GB/T 14233.1, samples representative of normal production, including final sterilization, are cleaned of surface contaminants and extracted using one of several preparation approaches. For devices with lumens, the fluid pathway is filled with purified water at nominal capacity. For materials and components, portions are immersed in purified water at a defined ratio, commonly in the range of a few grams of sample per tens of milliliters of extraction medium. The prevailing simulated-use condition is 37 °C ± 1 °C for 24 hours in a temperature-controlled incubator or water bath. Alternative extraction temperatures and durations may be applied when justified to accelerate extraction or reflect exaggerated worst-case exposure, consistent with the rationale framework of ISO 10993-12.

Determination Procedure

The gravimetric determination follows a defined sequence to ensure reproducibility:

• Prepare a blank control using the same purified water and identical procedure without the test sample, to correct for background contribution of the medium, glassware, and environment
• Condition an evaporating dish made of quartz, platinum, or borosilicate glass to constant weight at 105 °C in a drying oven, cooling it in a desiccator before each weighing on an analytical balance with 0.1 mg readability
• Transfer a measured volume of the test extract, typically 50 mL, into the pre-weighed dish and evaporate gently to near dryness on a water bath
• Dry the dish and residue at 105 °C ± 2 °C for approximately two hours, cool in a desiccator for at least 30 minutes, and weigh
• Repeat the drying, cooling, and weighing cycle until the difference between two consecutive weighings does not exceed the constant-weight criterion, commonly 0.3 mg
• Apply the identical procedure to the blank control solution

Calculation and Expression of Results

The evaporation residue is calculated as the mass of residue in the test extract minus the corresponding blank value. Results are reported in milligrams for the tested extract volume, or normalized to milligrams per liter or milligrams per device as required by the applicable product standard. Parallel determinations are performed and the results assessed for agreement before reporting.

Acceptance Criteria

Product standards for infusion, transfusion, and injection equipment commonly specify a limit of 5 mg or less for the evaporation residue of the water extract per defined test portion, with separate provisions where additional media apply. The exact limit must always be verified against the specific product standard applicable to the device under test, since harmonized national and international standards may assign different thresholds.

Quality Assurance Considerations

Reliable results depend on strict control of the blank, because the measured residue quantities are small. Key controls include the use of high-purity water with a verified low residue background, dust-free handling, calibrated balances and ovens, pre-cleaned glassware, replicate determinations, and full documentation of extraction conditions. Laboratories operating under ISO/IEC 17025 quality management systems apply these controls within validated test procedures.

Applications

Evaporation residue testing supports multiple quality, regulatory, and engineering objectives across the medical device lifecycle:

• National medical device registration and market approval dossiers, where chemical characterization data demonstrate conformity with recognized standards
• Batch release testing of disposable sterile devices as part of routine chemical quality control
• Supplier qualification and incoming inspection of polymers, elastomers, tubing, and films
• Change control evaluation when modifying materials, formulations, molding parameters, sterilization modality, or packaging
• Supporting data for biocompatibility assessments under the ISO 10993 series, where aggregate residue values help scope subsequent targeted extractables and leachables studies
• Stability and aging studies to verify that migration levels remain acceptable over the declared shelf life
• Root cause investigations following production deviations, sterilization excursions, or customer complaints
• Comparative benchmarking of candidate materials during design and development

FAQ

What is evaporation residue in medical device testing? It is the total mass of non-volatile substances that migrate from a device or material into a defined extract, measured after evaporating the extract and drying the remaining residue to constant weight. It provides an aggregate, non-specific indication of migratable impurities such as additives, oligomers, and processing residues.

Which standards govern evaporation residue testing for medical devices? GB/T 14233.1 specifies the reference method for infusion, transfusion, and injection equipment, and product standards such as GB 8368, GB 8369, and GB/T 15810 define applicable limits. The test also supports chemical characterization strategies aligned with ISO 10993-12 and ISO 10993-18. Accredited third-party laboratories select the standard appropriate to the device type and target market.

What extraction conditions are used? The prevailing simulated-use condition is purified water at 37 °C for 24 hours, either filling the device fluid pathway or immersing cut material portions at a defined ratio. Justified alternative conditions, such as elevated temperature or extended duration, may be used for exaggerated worst-case assessment.

What is a typical acceptance limit? Many product standards for infusion and injection devices set a limit of 5 mg or less for the residue of a standard extract portion. The applicable limit varies by device category and jurisdiction, so the relevant product standard must always be consulted.

How much sample is required for testing? Testing usually requires several complete sterile devices drawn from the same production batch, or a representative mass of raw material, together with retained packaging. The exact quantity depends on device geometry and the extraction approach specified by the standard.

What is the typical turnaround time? Because the procedure includes a 24-hour extraction cycle plus repeated drying and constant-weight verification, laboratories commonly report results within five to ten working days of sample receipt, depending on the scope of accompanying chemical tests.

How does this test relate to full extractables and leachables studies? Evaporation residue is a rapid, low-cost screening measurement of total non-volatile migrants. When results are elevated or when risk assessment requires compound-specific data, it is followed by chromatographic and spectroscopic identification and quantification of individual extractable substances under ISO 10993-18.